Thus, combined targeting of XIAP with Bcl-2, which blocks apoptotic signalling at the mitochondrial level and downstream of it, with simultaneous stimulation of Fas facilitates apoptosis in RCC. This evidence concerns the gene BCL2 and renal cell carcinoma.